Schonfeld Strategic Advisors’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-568,293
Closed -$20.4M 2997
2022
Q4
$20.4M Buy
+568,293
New +$14.2M 0.17% 166

Schonfeld Strategic Advisors's IMGO Position: Q1 2023 in Review

Schonfeld Strategic Advisors sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 568,293 shares — an estimated $20.4M sold.

Schonfeld Strategic Advisors first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $20.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Schonfeld Strategic Advisors reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 568,293 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $20.4M.
  • Schonfeld Strategic Advisors first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Imago BioSciences, Inc. Common stock position peaked at $20.4M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.